DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Public ClinicalTrials.gov record NCT01256684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
DHEA Against Vaginal Atrophy (Placebo-controlled, Double-blind and Randomized Phase III Study of 3-month Intravaginal DHEA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this Phase III trial is to confirm the efficacy of intravaginal dehydroepiandrosterone (DHEA) in postmenopausal women with vaginal atrophy.
Study identification
- NCT ID
- NCT01256684
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 255 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 75 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2010 (Type not available)
- Primary completion
- Aug 2011 (Actual)
- Completion
- Nov 2011 (Actual)
- Last update posted
- Jun 26, 2017
2010 – 2011
United States locations
- U.S. sites
- 24
- U.S. states
- 18
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| EndoCeutics site # 39 | Montgomery | Alabama | 36117 | — |
| EndoCeutics site # 14 | Tucson | Arizona | 85712 | — |
| EndoCeutics site # 21 | Sacramento | California | 95821 | — |
| EndoCeutics site # 30 | San Diego | California | 92108 | — |
| EndoCeutics site # 17 | San Diego | California | 92120 | — |
| EndoCeutics site # 36 | Denver | Colorado | 80218 | — |
| EndoCeutics site # 42 | Milford | Connecticut | 06460 | — |
| EndoCeutics site # 45 | Boynton Beach | Florida | 33472 | — |
| EndoCeutics site # 26 | Jacksonville | Florida | 32207 | — |
| EndoCeutics site # 23 | Sandy Springs | Georgia | 30328 | — |
| EndoCeutics site # 10 | Meridian | Idaho | 83642 | — |
| EndoCeutics site # 27 | Baltimore | Maryland | 21285-6815 | — |
| EndoCeutics site # 22 | Kalamazoo | Michigan | 49009 | — |
| EndoCeutics site # 25 | Lincoln | Nebraska | 68510 | — |
| EndoCeutics site # 28 | Moorestown | New Jersey | 08057 | — |
| EndoCeutics site # 44 | New Brunswick | New Jersey | 08901 | — |
| EndoCeutics site # 19 | New York | New York | 10016 | — |
| EndoCeutics site # 16 | Durham | North Carolina | 27713 | — |
| EndoCeutics site # 05 | Cleveland | Ohio | 44122 | — |
| EndoCeutics site # 15 | Columbus | Ohio | 43213 | — |
| EndoCeutics site # 35 | Pittsburgh | Pennsylvania | 15206 | — |
| EndoCeutics site # 09 | West Jordan | Utah | 84088 | — |
| EndoCeutics site # 31 | Charlottesville | Virginia | 22903 | — |
| EndoCeutics site # 03 | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01256684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01256684 live on ClinicalTrials.gov.